Roivant Sciences (ROIV) Gross Profit (2020 - 2025)

Roivant Sciences has reported Gross Profit for 6 years, with the latest figure at $1.3 million in Q4 2025.

• For the quarter ending Q4 2025, Gross Profit fell 85.17% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2025 stood at $13.5 million (down 62.55% YoY), and the FY2026 full-year result was $7.0 million, down 75.21% from the prior year.
• Gross Profit for Q4 2025 stood at $1.3 million, down from $1.5 million in the prior quarter.
• The five-year high for Gross Profit was $23.0 million in Q4 2021, with the low at $1.3 million in Q4 2025.
• Historically, Gross Profit has averaged $8.3 million across 5 years, with a median of $7.6 million in 2021.
• Annual changes were most pronounced in 2021 — Gross Profit surged 1150.99% — and 2025, when it slumped 85.17%.
• Roivant Sciences' Gross Profit stood at $23.0 million in 2021, then plunged by 41.34% to $13.5 million in 2022, then gained by 14.1% to $15.4 million in 2023, then sank by 42.99% to $8.8 million in 2024, then tumbled by 85.17% to $1.3 million in 2025.
• The last three Gross Profit figures came in at $1.3 million (Q4 2025), $1.5 million (Q3 2025), and $2.0 million (Q2 2025), per Business Quant data.